Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Idm Pharma, Inc. (IDMI) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Idm Pharma, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 822206.
Total stock buying since 2005: $0.
Total stock sales since 2005: $95,580.
Total stock option exercises since 2005: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2009 | 0 | $0 | 54,000 | $95,580 | 0 | $0 |
2005 | 0 | $0 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2009-04 | 0 | $0 | 54,000 | $95,580 | 0 | $0 |
2005-08 | 0 | $0 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2009-04-01 | Palo Alto Healthcare Master Fund, L.p. (10% Owner) | Sale | 54,000 | 1.77 | 95,580 |
2005-08-16 | Romet-lemonne Jean-loup (CEO) | Buy | 0 | .00 | 0 |
2005-08-16 | Deleage Jean (Director) | Buy | 0 | .00 | 0 |
2005-08-16 | Drakeman Donald L (Chief Executive) | Buy | 0 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of IDMI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Idm Pharma, Inc. (symbol IDMI, CIK number 822206) see the Securities and Exchange Commission (SEC) website.